Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GTBP

GT Biopharma, Inc.

Healthcare · USD

Set alert

Price alert · GTBP

All alert types
5.32 USD -0.28 -5.00%
As of Oct 30, 2026 Extended hours 5.58 +4.82%
Bid
5.19 × 1
Ask
5.51 × 1
5.32 Day range 5.54
0.554 52-week range 20.42
YTD
+577.71%
1 year
+747.13%
Open
5.47
Prev close
5.60
Mkt cap
10.96M
Vol
20.27K
Avg vol
64.76K
EPS
-147.50
P/E
0.00
Div yield
0.00%
More statistics
Low
5.32
High
5.54
Forward P/E
-0.26
Beta
0.57
Short ratio
0.71
Inst. own
67.52%
Dividend
0.00
Ex-div date
Earnings
Apr 4, 2024
50-d avg
2.76
200-d avg
3.00
1y target
11.00

5D chart

Chart tools
Interval
1m5m15m30m
GTBP five-day price chart5.095.265.445.615.78Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-185.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -0.1×
FY 2016: 0.2×FY 2017: -15.6×FY 2018: -3.8×FY 2019: -3.6×FY 2020: -33.5×FY 2021: -44.4×FY 2022: -40.3×FY 2023: -1.4×FY 2024: -0.4×FY 2025: -0.1×
FY 2016 5y median -1.4× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.7×
FY 2016: -0.1×FY 2017: 8.9×FY 2018: 84.9×FY 2019: -7.3×FY 2020: -32.4×FY 2021: 118×FY 2022: 72.2×FY 2023: 1.4×FY 2024: -3.5×FY 2025: 0.7×
FY 2016 5y median 1.4× FY 2025
P/FCF -0.3×
FY 2016: -1.1×FY 2017: -412×FY 2018: -91.4×FY 2019: -38.2×FY 2020: -131×FY 2021: -165×FY 2022: -55.6×FY 2023: -1.2×FY 2024: -0.4×FY 2025: -0.3×
FY 2016 5y median -1.2× FY 2025
EV/EBITDA 0.1×
FY 2016: -1.6×FY 2017: -16.5×FY 2018: -4.0×FY 2019: -4.2×FY 2020: -38.8×FY 2021: -44.7×FY 2022: -40.1×FY 2023: 1.6×FY 2024: -0.1×FY 2025: 0.1×
FY 2016 5y median -0.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -298.3%
FY 2016: -87.6%FY 2017: -0.2%FY 2018: -1.1%FY 2019: -2.6%FY 2020: -0.8%FY 2021: -0.6%FY 2022: -1.8%FY 2023: -85.9%FY 2024: -223.0%FY 2025: -298.3%
FY 2016 5y median -85.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -490.0%
FY 2016: -52.1%FY 2017: -57.2%FY 2018: -2246.2%FY 2019: 201.9%FY 2020: 96.7%FY 2021: -264.8%FY 2022: -178.0%FY 2023: -101.6%FY 2024: 788.1%FY 2025: -490.0%
FY 2016 5y median -178.0% FY 2025
ROIC -214.7%
FY 2016: 144.0%FY 2017: -53.9%FY 2018: -1127.8%FY 2019: 192.5%FY 2020: 218.3%FY 2021: -262.1%FY 2022: -178.5%FY 2023: -180.2%FY 2024: 860.1%FY 2025: -214.7%
FY 2016 5y median -180.2% FY 2025
ROA -349.8%
FY 2016: 39072.0%FY 2017: -56.7%FY 2018: -1020.5%FY 2019: -9759.3%FY 2020: -499.8%FY 2021: -180.3%FY 2022: -124.8%FY 2023: -53.8%FY 2024: -311.0%FY 2025: -349.8%
FY 2016 5y median -180.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 13.5%
FY 2016: -5.0%FY 2017: -1346.2%FY 2018: -84.5%FY 2019: 95.4%FY 2020: 41.0%FY 2021: -750.3%FY 2022: 63.0%FY 2023: 36.1%FY 2024: -5.8%FY 2025: 13.5%
FY 2016 FY 2025
EPS (diluted) 9.9%
FY 2016: 104.3%FY 2017: -100.2%FY 2018: 39.6%FY 2019: 87.0%FY 2020: 43.5%FY 2021: 68.1%FY 2022: 68.0%FY 2023: -754.5%FY 2024: -23.0%FY 2025: 9.9%
FY 2016 FY 2025
Free Cash Flow -0.1%
FY 2016: 58.6%FY 2017: -181.6%FY 2018: -97.1%FY 2019: 65.8%FY 2020: -98.5%FY 2021: -114.9%FY 2022: 2.5%FY 2023: 41.8%FY 2024: -45.8%FY 2025: -0.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.5×
FY 2016: 0.0×FY 2017: 0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 3.1×FY 2022: 3.4×FY 2023: 2.1×FY 2024: 0.7×FY 2025: 3.5×
FY 2016 5y median 3.1× FY 2025
Quick Ratio 3.5×
FY 2016: 0.0×FY 2017: 0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 3.1×FY 2022: 3.4×FY 2023: 2.1×FY 2024: 0.7×FY 2025: 3.5×
FY 2016 5y median 3.1× FY 2025
Debt / Equity 0.0×
FY 2016: -0.7×FY 2017: 0.0×FY 2018: 0.9×FY 2019: -0.7×FY 2020: -0.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: -1.3×FY 2017: 0.0×FY 2018: -0.0×FY 2019: -0.4×FY 2020: -0.8×FY 2021: 0.2×FY 2022: 0.3×FY 2023: -0.2×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -97.8×
FY 2016: -1.4×FY 2017: -15.8×FY 2018: -27.4×FY 2019: -5.4×FY 2020: -2.0×FY 2021: -80.1×FY 2022: -2657×FY 2023: -63.7×FY 2024: 0.0×FY 2025: -97.8×
FY 2016 5y median -80.1× FY 2025

Dividends

Dividend Yield 5.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 5.3%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -0.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -0.8%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31